As of 2025-05-19, the EV/EBITDA ratio of Evrofarma SA (EVROF.AT) is 7.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EVROF.AT's latest enterprise value is 40.97 mil EUR. EVROF.AT's TTM EBITDA according to its financial statements is 5.76 mil EUR. Dividing these 2 quantities gives us the above EVROF.AT EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 6.1x - 7.7x | 6.8x |
| Forward P/E multiples | 5.3x - 6.9x | 6.0x |
| Fair Price | 1.47 - 2.24 | 1.85 |
| Upside | -26.5% - 11.9% | -7.6% |
| Date | EV/EBITDA |
| 2025-05-16 | 7.11 |
| 2025-05-15 | 7.02 |
| 2025-05-14 | 6.97 |
| 2025-05-13 | 6.87 |
| 2025-05-12 | 6.90 |
| 2025-05-09 | 6.86 |
| 2025-05-08 | 6.85 |
| 2025-05-07 | 6.80 |
| 2025-05-06 | 6.86 |
| 2025-05-05 | 6.94 |
| 2025-05-02 | 6.84 |
| 2025-04-30 | 6.81 |
| 2025-04-29 | 6.92 |
| 2025-04-28 | 6.94 |
| 2025-04-25 | 6.97 |
| 2025-04-24 | 6.98 |
| 2025-04-23 | 6.98 |
| 2025-04-22 | 6.87 |
| 2025-04-17 | 6.77 |
| 2025-04-16 | 6.78 |
| 2025-04-15 | 6.80 |
| 2025-04-14 | 6.59 |
| 2025-04-11 | 6.48 |
| 2025-04-10 | 6.52 |
| 2025-04-09 | 6.39 |
| 2025-04-08 | 6.42 |
| 2025-04-07 | 6.28 |
| 2025-04-04 | 6.60 |
| 2025-04-03 | 6.64 |
| 2025-04-02 | 6.78 |
| 2025-04-01 | 6.75 |
| 2025-03-31 | 6.71 |
| 2025-03-28 | 6.83 |
| 2025-03-27 | 6.86 |
| 2025-03-26 | 6.87 |
| 2025-03-24 | 6.80 |
| 2025-03-21 | 6.73 |
| 2025-03-20 | 6.86 |
| 2025-03-19 | 6.78 |
| 2025-03-18 | 6.75 |
| 2025-03-17 | 6.90 |
| 2025-03-14 | 6.90 |
| 2025-03-13 | 6.77 |
| 2025-03-12 | 6.71 |
| 2025-03-11 | 6.72 |
| 2025-03-10 | 6.71 |
| 2025-03-07 | 6.68 |
| 2025-03-06 | 6.73 |
| 2025-03-05 | 6.70 |
| 2025-03-04 | 6.62 |